ReviewFrontiers in neurology2025
Benign paroxysmal positional vertigo a systematic review of the effects of comorbidities.
Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Betahistine for residual dizziness after canalith repositioning in benign paroxysmal positional vertigo: a systematic review of randomized controlled trials.Frontiers in pharmacology · 2026Pooled it
- Construction of a recurrence risk prediction model for benign paroxysmal positional vertigo.Acta neurologica Belgica · 2026Article
- [Effect of body mass index on residual dizziness after repositioning in benign paroxysmal positional vertigo].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026Article
- Recurrence of benign paroxysmal positional vertigo: risk factors and outcomes.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Association of sleep quality and inner-ear-specific biomarkers Otolin-1 and otoconin-90 with disease severity in benign paroxysmal positional vertigo.Frontiers in medicine · 2026Article
- Association between systemic inflammatory markers and recurrence risk in benign paroxysmal positional vertigo: a retrospective cohort study.Acta biochimica Polonica · 2026Article
- The Association Between Head Trauma and BPPV: A Nested Case-Control Study Using a National Health Screening Cohort.Diagnostics (Basel, Switzerland) · 2025Article
- Effect of canalith repositioning on resting-state brain functional connectivity in patients with benign paroxysmal positional vertigo.Frontiers in neurology · 2025Article
- A minimal ion-chemistry model for predicting benign paroxysmal positional vertigo risk based on endolymphatic calcium and pH.Frontiers in neurology · 2025Article
- Association between diabetes mellitus, hypertension, migraine, and recurrence risk in benign paroxysmal positional vertigo: a retrospective cohort study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of benign paroxysmal positional vertigo (BPPV) increases with age, as does the occurrence of other chronic health conditions. Although treatment with canalith-repositioning procedures (CRPs) is relatively successful, efficacy on the first attempt varies. Several studies have examined the influence of risk factors on BPPV occurrence and the efficacy of initial CRPs. However, findings are controversial. The objective of this study is to identify comorbidities associated with BPPV occurrence and explore their influence on the success of initial CRPs. Methods: The electronic databases PubMed, Scopus, Web of Science, Embase, MEDLINE and CINAHL were searched to identify eligible English original studies published from January 2019 to June 2024. All search results were reviewed based on our inclusion and exclusion criteria. Results: Of the 463 studies identified, 50 studies that satisfied the inclusion criteria were analysed. Eighteen studies focused on BPPV occurrence, 24 on the initial-CRP outcome and eight on both BPPV occurrence and the initial-CRP outcome. Twenty-five risk factors and comorbidities were identified to be associated with BPPV occurrence, and 15 were noted to impact the efficacy of the initial CRP. The most common reported risk factor for BPPV occurrence was head trauma (16 studies) and showed the poorest success rate after one CRP requiring a maximum of 18 manoeuvres to reach complete resolution (9 studies). Other factors included cardiovascular and endocrine comorbidities, neurological/neurotological comorbidities, musculoskeletal comorbidities, anxiety, obsessive-compulsive disorder, body mass index, serum vitamin D level and idiopathic BPPV. Conclusion: This systematic review assess the strength of evidence of risk factors influencing the development of BPPV and outcome of the initial CRP. Hypertension, hypotension, anaemia, ischaemic heart disease, hyperlipidaemia, stroke, diabetes mellitus, hypothyroidism, migraine, vestibular disorders, peripheral neuropathy, osteoporosis, cervical spondylosis, head trauma and low vitamin D were associated with BPPV incidence. Low levels of vitamin D, head trauma, migraine, inner ear diseases including Ménière's disease, hypertension, high cholesterol, diabetes mellitus, hypothyroidism, hyperlipidaemia, osteoporosis, and reduced cervical mobility are all associated with failed first canal repositioning manoeuvre. There is an identified need to explore risk factors across different BPPV subtypes and their impact on the efficacy of various treatment manoeuvres.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.